- Home
- MNKD vs JBLU Comparison
MNKD vs JBLU Comparison
Compare MNKD & JBLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- JBLU
- Stock Information
- Founded
- MNKD 1991
- JBLU 1998
- Country
- MNKD United States
- JBLU United States
- Employees
- MNKD N/A
- JBLU N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- JBLU Air Freight/Delivery Services
- Sector
- MNKD Health Care
- JBLU Consumer Discretionary
- Exchange
- MNKD Nasdaq
- JBLU Nasdaq
- Market Cap
- MNKD 1.8B
- JBLU 2.0B
- IPO Year
- MNKD 2004
- JBLU N/A
- Fundamental
- Price
- MNKD $6.80
- JBLU $7.06
- Analyst Decision
- MNKD Strong Buy
- JBLU Hold
- Analyst Count
- MNKD 5
- JBLU 10
- Target Price
- MNKD $8.40
- JBLU $6.43
- AVG Volume (30 Days)
- MNKD 2.9M
- JBLU 19.6M
- Earning Date
- MNKD 11-07-2024
- JBLU 10-29-2024
- Dividend Yield
- MNKD N/A
- JBLU N/A
- EPS Growth
- MNKD N/A
- JBLU N/A
- EPS
- MNKD 0.08
- JBLU N/A
- Revenue
- MNKD $267,200,000.00
- JBLU $9,327,000,000.00
- Revenue This Year
- MNKD $46.83
- JBLU N/A
- Revenue Next Year
- MNKD $14.40
- JBLU $5.55
- P/E Ratio
- MNKD $85.77
- JBLU N/A
- Revenue Growth
- MNKD 51.35
- JBLU N/A
- 52 Week Low
- MNKD $3.17
- JBLU $4.09
- 52 Week High
- MNKD $7.63
- JBLU $8.07
- Technical
- Relative Strength Index (RSI)
- MNKD 47.15
- JBLU 59.10
- Support Level
- MNKD $6.61
- JBLU $6.25
- Resistance Level
- MNKD $7.44
- JBLU $7.44
- Average True Range (ATR)
- MNKD 0.35
- JBLU 0.35
- MACD
- MNKD -0.05
- JBLU 0.09
- Stochastic Oscillator
- MNKD 18.63
- JBLU 80.10
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The operating segments of company are Domestic & Canada, Caribbean & Latin America and Atlantic. Majority of revenue is generated from Domestic & Canada segment.